Treatment Options Are Expanding for Benign Hematologic Disorders
September 24th 2019Kanwarpal S. Kahlon, MD, discusses current treatment options for patients with aplastic anemia, immune thrombocytopenic purpura, and thrombotic thrombocytopenic purpura, as well as future research for the field.
Read More
Encorafenib/Binimetinib Combo Continues to Show Survival Benefit in BRAF-Mutant Melanoma
September 3rd 2019Encorafenib (Braftovi) plus binimetinib (Mektovi) had superior overall survival and progression-free survival compared with encorafenib or vemurafenib (Zelboraf) alone in patients with BRAF V600–mutant melanoma.
Read More